Primary High Risk Lobular Breast Cancer clinical trials

Explore recruiting primary high risk lobular breast cancer clinical trials.

Recruiting primary high risk lobular breast cancer studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Primary High Risk Lobular Breast Cancer trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Phase II neoadjuvant study evaluating capivasertib plus fulvestrant vs fulvestrant in patients with primary high-risk lobular breast cancer- LOBSTER

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Primary High Risk Lobular Breast Cancer trials by city

Primary High Risk Lobular Breast Cancer in Toronto Primary High Risk Lobular Breast Cancer in Vancouver Primary High Risk Lobular Breast Cancer in Montreal Primary High Risk Lobular Breast Cancer in Calgary Primary High Risk Lobular Breast Cancer in Edmonton Primary High Risk Lobular Breast Cancer in Ottawa Primary High Risk Lobular Breast Cancer in Winnipeg Primary High Risk Lobular Breast Cancer in Quebec City Primary High Risk Lobular Breast Cancer in Hamilton Primary High Risk Lobular Breast Cancer in Kitchener Primary High Risk Lobular Breast Cancer in London Primary High Risk Lobular Breast Cancer in Halifax Primary High Risk Lobular Breast Cancer in New York Primary High Risk Lobular Breast Cancer in Los Angeles Primary High Risk Lobular Breast Cancer in Chicago Primary High Risk Lobular Breast Cancer in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease